Previous data in a pancreatic cancer model showed the existence of both the plasma membrane and a mitochondrial variant of ASCT2, which was suggested to be critical for glutamine-dependent mTORC1 activation required for cell survival (Yoo et al, 2020). This evidence concerns the gene SLC1A5 and familial pancreatic carcinoma.